Viewing data from:

TETRABENAZINE

ANDA

TETRABENAZINE | A206093 | APOTEX INC

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: XENAZINE(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-10-21 | 2 NDCs

Highest NADAC/Unit

$1.30

per ea

Lowest NADAC/Unit

$0.6740

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
60505388307TETRABENAZINE 25 MG TABLET	$1.30	EA	Generic	—	2026-10-21
60505388207TETRABENAZINE 12.5 MG TABLET	$0.6740	EA	Generic	—	2026-10-21

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$117.72

Highest Price

$208.24

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
51407-0480-12TETRABENAZINE 12.5MG TAB	$208.24	FSS	Golden State Medical Supply, Inc.	06/14/2028
51407-0481-12TETRABENAZINE 25MG TAB	$117.72	FSS	Golden State Medical Supply, Inc.	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain12 active DMFs

11 active API suppliers hold Drug Master Files for this ingredient.

CORDEN PHARMA CHENOVETETRABENAZINE

DMF 166832003

CHEMWERTH INCTETRABENAZINE(NON-STERILE BULK DRUG SUBSTANCE)

DMF 249462011

HETERO DRUGS LTDTETRABENAZINE

DMF 261132012

CENTAUR PHARMACEUTICALS PVT LTDTETRABENAZINE

DMF 263082012

APOTEX PHARMACHEM INDIA PVT LTDTETRABENAZINE

DMF 271352013

MATRIX PHARMACORP PRIVATE LTDTETRABENAZINE

DMF 271472013

SUN PHARMACEUTICAL INDUSTRIES LTDTETRABENAZINE

DMF 271862013

MATRIX PHARMACORP PRIVATE LTDTETRABENAZINE

DMF 281942014

ROLABO OUTSOURCING SLTETRABENAZINE

DMF 298282015

PIRAMAL PHARMA LTDTETRABENAZINE

DMF 324502018

INKE SATETRABENAZINE

DMF 372182022

AGNO PHARMATETRABENAZINE

DMF 401142024

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 12.5MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Mar 17, 2020

No patent or exclusivity listings for this strength.

#002 — 25MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Mar 17, 2020